Females, Pregnancy & Chronic Urticaria: What Doctors Should Know

Females, Pregnancy & Chronic Urticaria: What Doctors Should Know

In this episode, Dr. Sophia Neisinger welcomes Prof. Emek Kocatürk, leading urticaria researcher and UCARE expert from Istanbul, to explore the gender-specific aspects of chronic urticaria, with a special focus on pregnancy.


They discuss:

🔹 Why do more women than men suffer from chronic urticaria?
🔹 How does pregnancy affect urticaria symptoms and treatment response?
🔹 What medications are safe during pregnancy and breastfeeding?
🔹 How should physicians approach treatment decisions with female patients?

Prof. Kocatürk shares key insights from the PREG-CU study, involving over 300 pregnant CSU patients, and explains why half of them improve during pregnancy. She outlines practical treatment guidelines for antihistamines and omalizumab use during pregnancy and breastfeeding, discusses estrogen’s inflammatory role, and gives tips for shared decision-making in clinical care.

Join us for an important and empowering episode that sheds light on female-specific urticaria challenges and how to manage them with evidence-based confidence.


Key Learnings from the Episode

70% of CSU patients are female, pointing to hormonal and autoimmune factors in disease susceptibility.

Female CSU patients suffer more: more angioedema, systemic symptoms, worse disease control, and more comorbidities like asthma, thyroid disease, and depression.

The PREG-CU study showed that 50% of CSU patients improve during pregnancy, offering hope to women planning to conceive.

Exacerbations during pregnancy are common and linked to worse pregnancy outcomes if untreated.

Antihistamines (especially cetirizine, loratadine) are safe in pregnancy; second-generation agents are preferred.

Omalizumab is safe in pregnancy and lactation, particularly starting in the second trimester.

Antihistamines can be safely continued and even up-dosed during breastfeeding.

Keeping CSU under control during and after pregnancy is essential for maternal well-being and newborn bonding.

Shared decision-making and good counseling reduce fear and improve patient experience.

Digital tools, registries like CURE and CARE, and collaborative research are key to improving care for women with urticaria.


Chapters

00:00 Understanding Chronic Urticaria: A Female Predominance

06:20 Pregnancy and Chronic Urticaria: What to Expect

11:36 Managing Urticaria During Pregnancy and Lactation

17:18 Fun Facts and Closing Thoughts

Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.


Feedback form:

ATU: ⁠⁠⁠⁠https://forms.office.com/e/m6a2uEdsUH


Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(121)

AI and the Future of Urticaria

AI and the Future of Urticaria

In this episode of the UCARE GA²LEN (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier and Prof. Hermenio Lima discuss the growing role of artificial intellig...

16 Jun 16min

Urticaria Triggers: Infection Insights

Urticaria Triggers: Infection Insights

In this episode of the UCARE GA²LEN (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier and Prof. Maia Gotua discuss the role of infections in acute and chroni...

19 Mai 16min

A New Era in Urticaria Treatment

A New Era in Urticaria Treatment

In this episode of “All Things Urticaria” — a podcast from UCARE, the Global Allergy and Asthma Excellence Network — Prof. Torsten Zuberbier and Prof. Ana Giménez-Arnau discuss the newly released inte...

23 Apr 19min

Managing Urticaria in Resource-Limited Settings

Managing Urticaria in Resource-Limited Settings

In this episode of the UCARE Global Allergy and Asthma Excellence Network podcast on Urticaria, Prof. Torsten Zuberbier speaks with Dr. Emma Kruger from Cape Town, South Africa, about managing urticar...

24 Mar 17min

Drug Survival of Omalizumab

Drug Survival of Omalizumab

In this episode of the Urticaria podcast series, Prof. Torsten Zuberbier speaks with Reineke Soegiharto, PhD candidate and dermatology resident from UMC Utrecht, about the international UCARE study DR...

24 Feb 17min

Visualizing Urticaria Worldwide

Visualizing Urticaria Worldwide

In this episode of the GA²LEN Urticaria Podcast, Professor Torsten Zuberbier is joined by Professor Simon Francis Thomsen from Denmark to introduce an exciting new global initiative within the UCARE n...

28 Jan 19min

A New Era for Urticaria Treatment

A New Era for Urticaria Treatment

In this short, conference-based episode, Professor Torsten Zuberbier, President of Global Allergy and Asthma Excellence Network, speaks with Professor Kiran Godse from Mumbai, India, directly from the...

18 Des 20255min

Measuring What Matters: PROMs in Urticaria Care

Measuring What Matters: PROMs in Urticaria Care

In this episode of the GA²LEN (Global Allergy and Asthma Excellence Network) Podcast on Everything Urticaria, Professor Torsten Zuberbier talks with Dr. Karsten Weller, a leading expert and developer ...

2 Des 202519min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
liberal-halvtime
rekommandert
forskningno
sinnsyn
villmarksliv
smart-forklart
dekodet-2
tomprat-med-gunnar-tjomlid
fjellsportpodden
rss-nysgjerrige-norge
noen-har-snakket-sammen
rss-inn-til-kjernen-med-sunniva-rose
rss-overskuddsliv
rss-paradigmepodden
vett-og-vitenskap-med-gaute-einevoll
rss-rekommandert
rss-bondevennen